| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |